Corpus ID: 32257388

THE IMPACT OF A TESTOSTERONE-BOOSTER SUPPLEMENT IN INCREASING SEXUAL FUNCTION AND LIBIDO .

@inproceedings{Kaufman2013THEIO,
  title={THE IMPACT OF A TESTOSTERONE-BOOSTER SUPPLEMENT IN INCREASING SEXUAL FUNCTION AND LIBIDO .},
  author={D. Kaufman and Alexander Battegay},
  year={2013}
}
Male sexual hormones – also known as androgens – are the key for development of male sexual characteristics during puberty and optimum functioning of sexual function. Testosterone is the principle androgen. Although produced by the Leydig cells of the testes, the secretion of testosterone is under control of the Hypothalamo-pituitary-gonadal (HPG) axis. Male hypogonadism increases with age. Middle-aged and older men reflect the majority of those suffering from androgenic hypogonadism. Restoring… Expand

References

SHOWING 1-10 OF 33 REFERENCES
Androgens and the aging male.
TLDR
There is some evidence that testosterone replacement leads to symptom relief, particularly with respect to muscle strength, bone mineral density, and erectile dysfunction, and exogenous androgens have not been consistently shown to have antidepressant activity. Expand
Hormone substitution in male hypogonadism
TLDR
Testosterone substitution is necessary in all hypogonadal patients, because androgen deficiency causes slight anemia, changes in coagulation parameters, decreased bone density, muscle atrophy, regression of sexual function and alterations in mood and cognitive abilities. Expand
Androgen replacement therapy and prostate safety.
TLDR
The current evidence does not support the view that appropriate treatment of hypogonadal elderly men with androgens has a causal relationship with prostate cancer, and a set of recommendations regarding androgen replacement therapy and prostate safety is proposed. Expand
Androgens and estrogens in benign prostatic hyperplasia: past, present and future.
TLDR
More work is needed to identify estrogens and associated signaling pathways in BPH in order to target BPH with dietary and therapeutic SERMs, and demonstrate that estrogen receptor signaling pathways may be important in the development and maintenance of BPH and LUTS. Expand
A practical guide to male hypogonadism in the primary care setting
TLDR
Testosterone treatment is contraindicated in subjects with prostate cancer or benign prostate hyperplasia and risks of treatment are perceived to be high by many physicians, however, these risks are often exaggerated and should not outweigh the benefits of testosterone treatment. Expand
Andropause: is androgen replacement therapy indicated for the aging male?
TLDR
Several small clinical trials indicate that testosterone replacement therapy can improve many of these findings; however, the studies have not been powered to assess potential risks, such as the need for invasive treatment of benign prostatic hyperplasia, development of a clinical prostate cancer, or cardiovascular events. Expand
Estradiol in elderly men
The role of estrogens in male physiology has become more evident, as a consequence of the discovery of human models of estrogen deficiency such as estrogen resistance or aromatase deficiency. InExpand
American Association of Clinical Endocrinologists Medical Guidelines for clinical practice for the evaluation and treatment of hypogonadism in adult male patients--2002 update.
TLDR
These therapies may be combined with assisted reproductive technologies such as in vitro fertilization with intracytoplasmic sperm injection, which may allow pregnancy to occur with very low numbers of sperm. Expand
Prostate cancer risk in testosterone-treated men
  • J. Raynaud
  • Medicine
  • The Journal of Steroid Biochemistry and Molecular Biology
  • 2006
TLDR
A study on a large prospective cohort of 10,049 men contributes to the gathering evidence that the long standing "androgen hypothesis" of increasing risk with increasing androgen levels can be rejected, suggesting instead that high levels within the reference range of androgens, estrogens and adrenal androgens decrease aggressive prostate cancer risk. Expand
Male hypogonadism. Part II: etiology, pathophysiology, and diagnosis
  • A. Seftel
  • Medicine
  • International Journal of Impotence Research
  • 2006
TLDR
It is important for clinicians to be acquainted with the signs and symptoms of hypogonadism, and to conduct appropriate laboratory testing and other assessments to determine the causes and inform the treatment of this condition. Expand
...
1
2
3
4
...